Evidence map›Paper›PMID 21171147›Full record

ArticleJournal of biomedical materials research. Part A2011

2010 Panel on the biomaterials grand challenges.

William Monty Reichert, Buddy D Ratner, James Anderson, Art Coury, Allan S Hoffman, Cato T Laurencin, David Tirrell

Abstract read
In one paragraph

Article in Journal of biomedical materials research. Part A, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Biodegradable Polyphosphazene-Based Blends for Regenerative Engineering.Regenerative engineering and translational medicine · 2017
    Article
  7. Article
  8. Review
  9. REGENERATIVE ENGINEERING: APPROACHES TO LIMB REGENERATION AND OTHER GRAND CHALLENGES.Regenerative engineering and translational medicine · 2015
    Article
  10. Article
  11. Review
  12. Short-term and long-term effects of orthopedic biodegradable implants.Journal of long-term effects of medical implants · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

William Monty ReichertDepartment of Biomedical Engineering, Duke University, Durham, North Carolina, USA. reichert@duke.edu
Buddy D Ratner
James Anderson
Art Coury
Allan S Hoffman
Cato T Laurencin
David Tirrell

Funding

2009 Biomaterials Gordon Research ConferenceR13EB009294 · NIBIB · GORDON RESEARCH CONFERENCES · PI REICHERT, WILLIAM MONTGOMERY · 2009 to 2009
$10k
NIBIB NIH HHS R13 EB009294
6 · The paper itself

Abstract

In 2009, the National Academy for Engineering issued the Grand Challenges for Engineering in the 21st Century comprised of 14 technical challenges that must be addressed to build a healthy, profitable, sustainable, and secure global community (http://www.engineeringchallenges.org). Although crucial, none of the NEA Grand Challenges adequately addressed the challenges that face the biomaterials community. In response to the NAE Grand Challenges, Monty Reichert of Duke University organized a panel entitled Grand Challenges in Biomaterials at the at the 2010 Society for Biomaterials Annual Meeting in Seattle. Six members of the National Academies-Buddy Ratner, James Anderson, Allan Hoffman, Art Coury, Cato Laurencin, and David Tirrell-were asked to propose a grand challenge to the audience that, if met, would significantly impact the future of biomaterials and medical devices. Successfully meeting these challenges will speed the 60-plus year transition from commodity, off-the-shelf biomaterials to bioengineered chemistries, and biomaterial devices that will significantly advance our ability to address patient needs and also to create new market opportunities.

Indexed as

Advisory CommitteesSocieties, ScientificArtificial LimbsBiocompatible MaterialsCongresses as TopicDevelopmental BiologyHumansRegenerative MedicineBiocompatible Materials

Identifiers

PMID21171147
PMCPMC4076103

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.